cupure logo
tradedealtrumptrade dealtariffshomeyearchinatrumpstax

GSK strikes £370m deal with Chinese rival Jiangsu Hengrui to develop up to a dozen new medicines

GSK strikes £370m deal with Chinese rival Jiangsu Hengrui to develop up to a dozen new medicines
The deal comes as GSK, led by chief exec Emma Walmsley (pictured) focuses on growing its pipeline to offset declining revenues.

Comments

Business News